We are live on ! Find out more
DMKJ

David M. Knott Jr Portfolio holdings

AUM $189M Turnover 22.11%
1-Year Est. Return 67.72%
This Fund
S&P 500
This Quarter Est. Return
+6.86%
1 Year Est. Return
+67.72%
3 Year Est. Return
+169.37%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$251M
AUM Growth
-$3.22M
Cap. Flow
-$11.3M
Cap. Flow %
-4.49%
Top 10 Hldgs %
65.99%
Holding
155
New
6
Increased
7
Reduced
10
Closed
7
Avg Time Held
1.1 years
Top 10 Avg Time Held
1.2 years
Top 20 Avg Time Held
1 year

Top Buys

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$3.01M
2
SGEN
Seagen Inc. Common Stock
SGEN
+$2.28M
3
ALKS icon
Alkermes
ALKS
+$2.03M
4
CHRS icon
Coherus Oncology
CHRS
+$1.45M
5
MCRB icon
Seres Therapeutics
MCRB
+$843K

Top Sells

Rank Stock Value
1
FBRT icon
Franklin BSP Realty Trust
FBRT
+$5.67M
2
GCVRZ
Sanofi Contingent Value Rights
GCVRZ
+$3.05M
3
VKTX icon
Viking Therapeutics
VKTX
+$2.61M
4
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
+$2.38M
5
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$1.51M

Sector Composition

Rank Sector Weight
1 Healthcare 30.52%
2 Materials 30.19%
3 Financials 13.16%
4 Industrials 6.99%
5 Miscellaneous 6.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
TWLVW icon
26
DELISTED
Twelve Seas Investment Company II Warrant
TWLVW
$1.92M 0.76%
166,666
– –
2021 Q4
6 quarters
WHWK icon
27
Whitehawk Therapeutics
WHWK
$173M
$1.78M 0.71%
261,000
+77,312
+42% +$601K
2022 Q2
4 quarters
EXE icon
28
Expand Energy Corp
EXE
$21B
$1.67M 0.67%
20,000
– –
2022 Q2
4 quarters
CVE icon
29
Cenovus Energy
CVE
$59B
$1.61M 0.64%
95,000
– –
2022 Q2
4 quarters
AB icon
30
AllianceBernstein
AB
$3.2B
$1.59M 0.63%
49,500
– –
2021 Q4
6 quarters
FIP icon
31
FTAI Infrastructure
FIP
$303M
$1.57M 0.62%
425,000
– –
2022 Q3
3 quarters
OVV icon
32
Ovintiv
OVV
$18.3B
$1.33M 0.53%
35,000
– –
2022 Q2
4 quarters
ACLX icon
33
DELISTED
Arcellx
ACLX
$1.26M 0.5%
40,000
+12,000
+43% +$459K
2023 Q1
1 quarter
INZY icon
34
DELISTED
Inozyme Pharma
INZY
$1.23M 0.49%
220,000
+60,000
+38% +$355K
2023 Q1
1 quarter
MOS icon
35
The Mosaic Company
MOS
$6.02B
$1.23M 0.49%
35,000
– –
2022 Q2
4 quarters
VKTX icon
36
Viking Therapeutics
VKTX
$3.48B
$1.23M 0.49%
75,549
-124,615
-62% -$2.61M
2021 Q4
6 quarters
RHP icon
37
Ryman Hospitality Properties
RHP
$8.65B
$1.15M 0.46%
12,400
– –
2021 Q4
6 quarters
PMGMW icon
38
DELISTED
Priveterra Acquisition Corp. II Warrant to purchase Class A common stock
PMGMW
$1.15M 0.46%
100,000
– –
2021 Q4
6 quarters
VRTX icon
39
Vertex Pharmaceuticals
VRTX
$129B
$1.06M 0.42%
3,000
-4,000
-57% -$1.35M
2021 Q4
6 quarters
CHRS icon
40
Coherus Oncology
CHRS
$165M
$1.05M 0.42%
+245,010
New +$1.45M
2023 Q2
0 quarters
MDLZ icon
41
Mondelez International
MDLZ
$80.4B
$1.02M 0.41%
14,000
– –
2021 Q4
6 quarters
XENE icon
42
Xenon Pharmaceuticals
XENE
$3.32B
$919K 0.37%
23,866
-16,134
-40% -$641K
2021 Q4
6 quarters
KMB icon
43
Kimberly-Clark
KMB
$34.6B
$828K 0.33%
6,000
– –
2021 Q4
6 quarters
DD icon
44
DuPont de Nemours
DD
$17.8B
$709K 0.28%
7,911
– –
2021 Q4
6 quarters
ABBV icon
45
AbbVie
ABBV
$501B
$679K 0.27%
5,037
– –
2021 Q4
6 quarters
FAZEW
46
DELISTED
FaZe Holdings Inc. Warrant
FAZEW
$671K 0.27%
+58,321
New +$1.88K
2023 Q2
0 quarters
CTVA icon
47
Corteva
CTVA
$8.59B
$663K 0.26%
11,563
– –
2021 Q4
6 quarters
ABEO icon
48
Abeona Therapeutics
ABEO
$266M
$645K 0.26%
160,000
– –
2022 Q4
2 quarters
DOW icon
49
Dow Inc
DOW
$21.4B
$593K 0.24%
11,136
– –
2021 Q4
6 quarters
KO icon
50
Coca-Cola
KO
$396B
$578K 0.23%
9,600
– –
2021 Q4
6 quarters
1
2
3 4 5

Similar funds

SCA
Sander Capital Advisors Seattle, Washington $189M AUM 13.06% 1-Year Est. Return
FI
FWG Investments Lexington, Kentucky $189M AUM 18.47% 1-Year Est. Return
MFS
Madrid Financial Services Manhattan Beach, California $189M AUM 30.12% 1-Year Est. Return
FRA
FFG Retirement Advisors Centennial, Colorado $189M AUM 16.39% 1-Year Est. Return
CAM
Councilmark Asset Management Knoxville, Tennessee $189M AUM 26.93% 1-Year Est. Return
BAG
Bauman Advisory Group Las Vegas, Nevada $189M AUM
SHC
SALT Holding Corp Wilmington, Delaware $189M AUM 34.63% 1-Year Est. Return
HC
Hara Capital Bellevue, Washington $190M AUM 42.56% 1-Year Est. Return

David M. Knott Jr's Q2 2023 Portfolio in Review

As of Q2 2023, David M. Knott Jr held 155 positions worth $251M, down 1.3% from $254M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

David M. Knott Jr withdrew a net $11.3M in Q2 2023, closing 7 positions and reducing 10 holdings. Its most notable exit was Sanofi Contingent Value Rights, an estimated $3.05M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 29% a quarter earlier, followed by Materials and Financials.

Against the trend, David M. Knott Jr opened a new position in Sanofi worth $3.02M.

  • David M. Knott Jr's largest Q2 2023 buy was Sanofi: 56,000 shares worth $3.02M.
  • David M. Knott Jr added most to Seagen Inc. Common Stock in Q2 2023, an estimated $2.28M increase.
  • David M. Knott Jr's biggest Q2 2023 reduction was Franklin BSP Realty Trust, cutting an estimated $5.67M.
  • David M. Knott Jr fully exited Sanofi Contingent Value Rights in Q2 2023, selling an estimated $3.05M.
  • David M. Knott Jr's ten largest holdings make up 66% of its $251M portfolio in Q2 2023.
  • David M. Knott Jr opened 6 new positions and closed 7 in Q2 2023.
  • David M. Knott Jr's portfolio value fell 1.3% quarter-over-quarter to $251M.

Based on David M. Knott Jr's 13F filing for Q2 2023, filed 11 Aug 2023.